Zavascki AP - Search Results

1

Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.

Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. Zavascki AP, et al. J Antimicrob Chemother. 2005 Dec;56(6):1148-51. doi: 10.1093/jac/dki390. Epub 2005 Oct 20. J Antimicrob Chemother. 2005. PMID: 16239284

2

Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.

Zavascki AP, Cruz RP, Goldani LZ. Zavascki AP, et al. J Hosp Infect. 2005 Feb;59(2):96-101. doi: 10.1016/j.jhin.2004.09.007. J Hosp Infect. 2005. PMID: 15620442

3

The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.

Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, Ramos F, Goldani LZ. Zavascki AP, et al. J Antimicrob Chemother. 2006 Aug;58(2):387-92. doi: 10.1093/jac/dkl239. Epub 2006 Jun 3. J Antimicrob Chemother. 2006. PMID: 16751638

4

High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital.

Zavascki AP, Goldani LZ, Gonçalves AL, Martins AF, Barth AL. Zavascki AP, et al. Epidemiol Infect. 2007 Feb;135(2):343-5. doi: 10.1017/S0950268806006893. Epub 2006 Jul 7. Epidemiol Infect. 2007. PMID: 16824253 Free PMC article.

5

Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study.

Zavascki AP, Barth AL, Fernandes JF, Moro AL, Gonçalves AL, Goldani LZ. Zavascki AP, et al. Crit Care. 2006;10(4):R114. doi: 10.1186/cc5006. Crit Care. 2006. PMID: 16882337 Free PMC article.

6

Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.

Zavascki AP, Barth AL, Gaspareto PB, Gonçalves AL, Moro AL, Fernandes JF, Goldani LZ. Zavascki AP, et al. J Antimicrob Chemother. 2006 Oct;58(4):882-5. doi: 10.1093/jac/dkl327. Epub 2006 Aug 8. J Antimicrob Chemother. 2006. PMID: 16895936

7

Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.

Zavascki AP, Soares FC, Superti SV, Silbert S, Silva FM, Barth AL. Zavascki AP, et al. Int J Antimicrob Agents. 2007 Aug;30(2):187-9. doi: 10.1016/j.ijantimicag.2007.03.001. Epub 2007 Apr 23. Int J Antimicrob Agents. 2007. PMID: 17452093 No abstract available.

8

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

Zavascki AP, Goldani LZ, Li J, Nation RL. Zavascki AP, et al. J Antimicrob Chemother. 2007 Dec;60(6):1206-15. doi: 10.1093/jac/dkm357. Epub 2007 Sep 17. J Antimicrob Chemother. 2007. PMID: 17878146 Review.

9

Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil.

Barth AL, de Abreu E Silva FA, Hoffmann A, Vieira MI, Zavascki AP, Ferreira AG, da Cunha LG Jr, Albano RM, de Andrade Marques E. Barth AL, et al. Among authors: zavascki ap. J Clin Microbiol. 2007 Dec;45(12):4077-80. doi: 10.1128/JCM.01386-07. Epub 2007 Oct 17. J Clin Microbiol. 2007. PMID: 17942657 Free PMC article.

10

Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.

Martins AF, Zavascki AP, Gaspareto PB, Barth AL. Martins AF, et al. Among authors: zavascki ap. Infection. 2007 Dec;35(6):457-60. doi: 10.1007/s15010-007-6289-3. Epub 2007 Nov 21. Infection. 2007. PMID: 18034208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters